BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 31582575)

  • 1. Conformational Changes in the 5-HT
    Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
    Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the molecular motions of 5-HT
    Peverini L; Shi S; Medjebeur K; Corringer PJ
    Elife; 2024 Jun; 12():. PubMed ID: 38913422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Length and amino acid sequence of peptides substituted for the 5-HT3A receptor M3M4 loop may affect channel expression and desensitization.
    McKinnon NK; Bali M; Akabas MH
    PLoS One; 2012; 7(4):e35563. PubMed ID: 22539982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
    Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
    Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
    Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
    Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors.
    Gasiorek A; Trattnig SM; Ahring PK; Kristiansen U; Frølund B; Frederiksen K; Jensen AA
    Biochem Pharmacol; 2016 Jun; 110-111():92-108. PubMed ID: 27086281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling and Mutational Analysis of the Binding Mode for the Multimodal Antidepressant Drug Vortioxetine to the Human 5-HT
    Ladefoged LK; Munro L; Pedersen AJ; Lummis SCR; Bang-Andersen B; Balle T; Schiøtt B; Kristensen AS
    Mol Pharmacol; 2018 Dec; 94(6):1421-1434. PubMed ID: 30257860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The L293 residue in transmembrane domain 2 of the 5-HT3A receptor is a molecular determinant of allosteric modulation by 5-hydroxyindole.
    Hu XQ; Lovinger DM
    Neuropharmacology; 2008 Jun; 54(8):1153-65. PubMed ID: 18436267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate and Inhibitor-Specific Conformational Changes in the Human Serotonin Transporter Revealed by Voltage-Clamp Fluorometry.
    Söderhielm PC; Andersen J; Munro L; Nielsen AT; Kristensen AS
    Mol Pharmacol; 2015 Oct; 88(4):676-88. PubMed ID: 26174773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A triad of residues is functionally transferrable between 5-HT
    Mosesso R; Dougherty DA
    J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function.
    Connolly CN; Wafford KA
    Biochem Soc Trans; 2004 Jun; 32(Pt3):529-34. PubMed ID: 15157178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+.
    Hu XQ; Lovinger DM
    J Physiol; 2005 Oct; 568(Pt 2):381-96. PubMed ID: 16096341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthosteric and Allosteric Activation of Human 5-HT
    Rodriguez Araujo N; Fabiani C; Mazzarini Dimarco A; Bouzat C; Corradi J
    Biophys J; 2020 Oct; 119(8):1670-1682. PubMed ID: 32946769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-HT3B subunit confers spontaneous channel opening and altered ligand properties of the 5-HT3 receptor.
    Hu XQ; Peoples RW
    J Biol Chem; 2008 Mar; 283(11):6826-31. PubMed ID: 18187416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation and desensitization induce distinct conformational changes at the extracellular-transmembrane domain interface of the glycine receptor.
    Wang Q; Lynch JW
    J Biol Chem; 2011 Nov; 286(44):38814-38824. PubMed ID: 21917927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT3 receptor ion size selectivity is a property of the transmembrane channel, not the cytoplasmic vestibule portals.
    McKinnon NK; Reeves DC; Akabas MH
    J Gen Physiol; 2011 Oct; 138(4):453-66. PubMed ID: 21948949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a 5-HT
    Price KL; Lummis SCR
    ACS Chem Neurosci; 2018 Jun; 9(6):1409-1415. PubMed ID: 29508995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modular design of Cys-loop ligand-gated ion channels: functional 5-HT3 and GABA rho1 receptors lacking the large cytoplasmic M3M4 loop.
    Jansen M; Bali M; Akabas MH
    J Gen Physiol; 2008 Feb; 131(2):137-46. PubMed ID: 18227272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols.
    Stevens R; Rüsch D; Solt K; Raines DE; Davies PA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):338-45. PubMed ID: 15831437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors.
    Gunthorpe MJ; Peters JA; Gill CH; Lambert JJ; Lummis SC
    J Physiol; 2000 Jan; 522 Pt 2(Pt 2):187-98. PubMed ID: 10639097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.